On the REPROCELL blog
Latest

Revolutionizing IBD Research with Innovative In Vitro Models
Catch a glimpse into the future of inflammatory bowel disease (IBD) research with our ground breaking in vitro models.
11 August 2025

Explore the crucial role of early genetic variant detection in iPSC cultures for ensuring safe, effective, and regulatory-compliant cell therapies. Learn about risk profiling and REPROCELL’s solutions.
01 August 2025

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation
Explore how subcutaneous artery assays enhance understanding of blood pressure regulation and aid in the development of safer, more effective cardiovascular drugs.
07 July 2025

Able Biott Single-use Bioreactors Enhance the Development of Disease Models and Cell Therapy
Discover how Able Biott single-use bioreactors enhance disease modeling and cell therapy development through scalable, efficient iPSC culture solutions.
03 July 2025